Protagonist Phase II data supports long-term efficacy of rusfertide in - The Pharma Letter

Protagonist Phase II data supports long-term efficacy of rusfertide in  The Pharma Letter

from "phlebotomist" - Google News https://bit.ly/3zyJz3K